AI주식인사이트AI Stock Insight
C

한국비엔씨

256840KOSDAQ기초 의약물질 제조업

48.8 / 100

Reference Date: 2026-07-24

Financial Score15.5 / 40
News Sentiment21.3 / 25
Momentum5.0 / 20
Disclosure7.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but PER raises overvaluation concerns. Declined 6.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Korea BNC is a biotech company established in 2007, specializing in the research, development, and distribution of medical devices, aesthetic equipment, pharmaceuticals, and cosmeceutical products based on hyaluronic acid and collagen. Its main revenue streams include aesthetic medical products (58.2%) and reagents/test equipment (25.2%), with growth driven by global partnerships in the medical and bio sectors.

Number of Employees

295people

Average Salary

49.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
81.54Industry Average 25.440.0Point

3.2x industry avg (risky)

PBR
0.70Industry Average 1.265.5Point

Lower than industry avg (good)

ROE
0.86Industry Average -6.033.5Point

Well below industry avg

Debt Ratio
9.67Industry Average 6.622.0Point

Higher than industry avg (caution)

Trend 2023~20254.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲8.8% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼3.9% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 6.6% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 2,440Won52-week high 6,05052-week low 2,310
1-month return2.0Point

1m -6.33% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 3Negative 1
  • Neutral주식등의대량보유상황보고서(일반)2026-07-13
  • Neutral주식등의대량보유상황보고서(일반)2026-06-29
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-29
  • Negative기타경영사항(자율공시) (의약품 회수·폐기 및 잠정 제조중지 등 명령 취소 소송 상고심 판결)2026-06-26